Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Lung cancer

  • The risk of post-operative pulmonary complications in lung resection candidates with normal forced expiratory volume in 1 s and diffusing capacity of the lung for carbon monoxide: a prospective multicentre study
    Ivan Cundrle, Zdenek Merta, Monika Bratova, Pavel Homolka, Ladislav Mitas, Vladimir Sramek, Michal Svoboda, Zdenek Chovanec, Milos Chobola, Lyle J. Olson, Kristian Brat
    ERJ Open Research Mar 2023, 9 (2) 00421-2022; DOI: 10.1183/23120541.00421-2022
  • Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
    Manuela Funke-Chambour, Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Athol U. Wells, Jacques Cadranel
    ERJ Open Research Oct 2022, 8 (4) 00469-2022; DOI: 10.1183/23120541.00469-2022
  • Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
    Yuriko Ishida, Satoshi Ikeda, Akimasa Sekine, Tomohisa Baba, Takashi Ogura
    ERJ Open Research Oct 2022, 8 (4) 00337-2022; DOI: 10.1183/23120541.00337-2022
  • 1-year mortality in lung cancer in France according to key timepoints of care pathways
    Axelle Rivière, Anne Isabelle Lecuyer, Emeline Laurent, Carole Lefebvre, Thierry Lecomte, Elodie Olivier, Delphine Carmier, Laurent Plantier, Leslie Grammatico-Guillon
    ERJ Open Research Oct 2022, 8 (4) 00157-2022; DOI: 10.1183/23120541.00157-2022
  • Pathological characteristics of mediastinal masses in Sri Lanka 2017–2021: a retrospective observational study
    Yasith Mathangasinghe, Saman Pradeep, Udeshika Perera, Ramani Punchihewa
    ERJ Open Research Oct 2022, 8 (4) 00256-2022; DOI: 10.1183/23120541.00256-2022
  • Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer
    Rolof G.P. Gijtenbeek, Vincent van der Noort, Joachim G.J.V. Aerts, Jeske A. Staal-van den Brekel, Egbert F. Smit, Frans H. Krouwels, Frank A. Wilschut, T. Jeroen N. Hiltermann, Wim Timens, Ed Schuuring, Joost D.J. Janssen, Martijn Goosens, Paul M. van den Berg, A. Joop de Langen, Jos A. Stigt, Ben E.E.M. van den Borne, Harry J.M. Groen, Wouter H. van Geffen, Anthonie J. van der Wekken
    ERJ Open Research Oct 2022, 8 (4) 00239-2022; DOI: 10.1183/23120541.00239-2022
  • Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors
    Emily Pei-Ying Lin, Li-Ching Huang, Jennifer Whisenant, Sally York, Travis Osterman, Jennifer Lewis, Wade Iams, Emily Skotte, Amanda Cass, Chih-Yuan Hsu, Yu Shyr, Leora Horn
    ERJ Open Research Oct 2022, 8 (4) 00684-2021; DOI: 10.1183/23120541.00684-2021
  • Gene expression profile of epithelial–mesenchymal transition in tumours of patients with nonsmall cell lung cancer: the influence of COPD
    Yingchen Xia, Jianhua Zha, Víctor Curull, Albert Sánchez-Font, Maria Guitart, Alberto Rodríguez-Fuster, Rafael Aguiló, Esther Barreiro
    ERJ Open Research Jul 2022, 8 (3) 00105-2022; DOI: 10.1183/23120541.00105-2022
  • Computed tomography on lung cancer screening is useful for adjuvant comorbidity diagnosis in developing countries
    Juliane Nascimento de Mattos, Carlos Eugênio Santiago Escovar, Manuela Zereu, Adalberto Sperb Rubin, Spencer Marcantonio Camargo, Tan-Lucien Mohammed, Ricardo Sales dos Santos, Nupur Verma, Diana Penha Pereira, Erique Guedes Pinto, Tiago Machuca, Tássia Machado Medeiros, Bruno Hochhegger
    ERJ Open Research Apr 2022, 8 (2) 00061-2022; DOI: 10.1183/23120541.00061-2022
  • Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges
    Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Jacques Cadranel, Athol U. Wells, Manuela Funke-Chambour
    ERJ Open Research Apr 2022, 8 (2) 00115-2022; DOI: 10.1183/23120541.00115-2022

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Acute lung injury and critical care (47)
  • Asthma and allergy (226)
  • CF and non-CF bronchiectasis (138)
  • COPD and smoking (344)
  • Epidemiology, occupational and environmental lung disease (59)
  • Genetics (29)
  • Interstitial and orphan lung disease (176)
  • Lung biology and experimental studies (84)
  • Lung cancer (77)
  • Lung imaging (59)
  • Lung structure and function (114)
  • Mechanisms of lung disease (4)
  • Paediatric pulmonology (111)
  • Pulmonary pharmacology and therapeutics (139)
  • Pulmonary vascular disease (93)
  • Respiratory clinical practice (94)
  • Respiratory infections and tuberculosis (353)
  • Sleep medicine (57)
  • Most Read
  • Twitter
Loading
  • Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
  • IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette
  • A potential harmful effect of dexamethasone in non-severe COVID-19: results from the COPPER-pilot study
  • Impact of N-acetyl-l-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study
  • ERS International Congress 2020: highlights from the General Pneumology Assembly
More...

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society